Tag: Nasdaq:MRVI
Maravai LifeSciences Announces Pricing of an Upsized Secondary Offering of Class A...
SAN DIEGO, April 07, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science...
Maravai LifeSciences Announces Launch of Proposed Secondary Offering of Class A Common...
SAN DIEGO, April 05, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science...
Maravai LifeSciences Offers End-to-End mRNA Production with the Launch of TriLink...
SAN DIEGO, March 15, 2021 (GLOBE NEWSWIRE) -- Maravai LifeSciences (NASDAQ: MRVI), a global provider of life science reagents and services...